Ganoderic acid X
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Bioactive by-products |
Catalog number | BBF-01481 |
CAS | 86377-53-9 |
Molecular Weight | 512.72 |
Molecular Formula | C32H48O5 |
Purity | ≥98% by HPLC |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Ganoderic acid X is a substance isolated from Ganoderma lucidum with anti-tumor activity.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | 15alpha-Acetoxy-3alpha-hydroxy-5alpha-lanosta-7,9(11),24-trien-26-oic acid; (24E)-3α-Hydroxy-15α-acetoxylanosta-7,9(11),24-triene-26-oic acid |
Storage | 2-8°C |
IUPAC Name | (E,6R)-6-[(3R,5R,10S,13R,14R,15S,17R)-15-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid |
Canonical SMILES | CC(CCC=C(C)C(=O)O)C1CC(C2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)O)C)C)C)OC(=O)C |
InChI | InChI=1S/C32H48O5/c1-19(10-9-11-20(2)28(35)36)24-18-27(37-21(3)33)32(8)23-12-13-25-29(4,5)26(34)15-16-30(25,6)22(23)14-17-31(24,32)7/h11-12,14,19,24-27,34H,9-10,13,15-18H2,1-8H3,(H,35,36)/b20-11+/t19-,24-,25+,26-,27+,30-,31-,32-/m1/s1 |
InChI Key | YCWGPALSXRBKTM-XGNRZNIMSA-N |
Appearance | Solid Powder |
Antibiotic Activity Spectrum | neoplastics (Tumor) |
Boiling Point | 625.5±55.0 °C at 760 mmHg |
Melting Point | 161-163°C |
BBF-03816 | Milbemycin oxime | Inquiry |
BBF-05880 | N-Me-L-Ala-maytansinol | Inquiry |
BBF-03516 | (±)-Naringenin | Inquiry |
BBF-04736 | 3-Indolepropionic acid | Inquiry |
BBF-02577 | Pneumocandin C0 | Inquiry |
BBF-01829 | Deoxynojirimycin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
